CALIFORNIA: Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented inventory control, compliance, and dispensing systems to the medical and retail industries, announced that they have been featured in The Wall Street Journal MarketWatch.
The article states that the medical marijuana industry, now legal in 20 states and Washington, D.C., could double next year, to $3 billion. “And owners and shareholders of some companies — including Medbox (MDBX), whose stock is up more than 800% in the past year, has certainly benefited from legalization.”
The article points out that under federal law, selling, producing, possessing and consuming marijuana is still a crime. However, Medbox is not engaged in the business of selling, producing, processing or consuming marijuana, and makes its revenues through consulting and sales of its patented inventory control system. This important distinction may be one of the reasons why Medbox has become a darling stock on Wall Street.